Dainik Bhaskar Hindi – bhaskarhindi.com, Hyderabad. Dr Reddy’s Laboratories on Tuesday said it received emergency-use authorization from the Drug Controller General of India (DCGI) to manufacture and market molanupiravir, a tablet for the treatment of COVID-19, soon followed by the brand’s pan-India The company will launch its Molnupiravir Capsule 200 mg under Molflu in India.
Hyderabad based company said
